Product Information

TIZANIDINE HCL 6 MG CAPSULE is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.1399 per EA under NDC 75834020915. Its NADAC has been published 352 times since Feb 26, 2020.

FDA first approved this application on Mar 26, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the TIZANIDINE HYDROCHLORIDE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TIZANIDINE HCL 6 MG CAPSULE

TIZANIDINE HYDROCHLORIDE
$0.1399per EA
High Outlier

Strength

6 mg/1

NDC

75834020915

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

TIZANIDINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA210021

FDA Approved

3/26/2019

TE Code

AB

On Market Since

9/26/2019

Pharmacological Classes

Adrenergic alpha2-Agonists
Central alpha-2 Adrenergic Agonist

Price Statistics

The NADAC for TIZANIDINE HCL 6 MG CAPSULE has been published 352 times since Feb 26, 2020, and over the history we have for it it has declined 85.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1399 per EA
All-time high$1.0054 (Apr 15, 2020)
All-time low$0.1252 (Jul 22, 2026)
52-week high$0.1436
52-week low$0.1252
Median price$0.2067
Average price$0.2654
Largest weekly change-50.9% (Jul 22, 2020)
Weeks tracked352
Tracking sinceFeb 26, 2020

Price History

1W

-2.6%

1M

-0.5%

3M

+4.8%

6M

+8.9%

1Y

-6.8%

3Y

-17.0%

5Y

-58.6%

All

-85.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the TIZANIDINE HYDROCHLORIDE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TIZANIDINE HCL 6 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TIZANIDINE HCL 6 MG CAPSULE, manufactured by Nivagen Pharmaceuticals Inc., is $0.1399 per EA (NDC 75834020915), effective Nov 18, 2026.

How has the price of TIZANIDINE HCL 6 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for TIZANIDINE HCL 6 MG CAPSULE has declined 85.8%. It has been tracked across 352 weekly CMS publications since Feb 26, 2020.

What are the highest and lowest recorded NADAC prices for TIZANIDINE HCL 6 MG CAPSULE?

Since Feb 26, 2020, the NADAC for TIZANIDINE HCL 6 MG CAPSULE has ranged from a low of $0.1252 (Jul 22, 2026) to a high of $1.0054 (Apr 15, 2020), with a median of $0.2067 per EA.

Are there cheaper alternatives to TIZANIDINE HCL 6 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of TIZANIDINE HCL 6 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures TIZANIDINE HCL 6 MG CAPSULE?

TIZANIDINE HCL 6 MG CAPSULE (NDC 75834020915) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.